GSK481
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | GSK481 is a novel benzoxazepinone (BOAz) series of RIP1 inhibitors. Receptor Interacting Protein Kinase 1 (RIP1) has been implicated as a key contributor to inflammation through the regulation of programmed necrosis. Inhibition of this kinase has been shown to hinder cell necrotic death, thereby establishing RIP1 as a viable target for the potential treatment of multiple inflammatory diseases. | ||
---|---|---|---|
Targets |
|
Catalog Num | A12615 |
---|---|
Formula | C21H19N3O4 |
Molecular Weight | 377.39 |
CAS Number | 1622849-58-4 |
SMILES | O=C(C1=NOC(CC2=CC=CC=C2)=C1)N[C@H]3COC4=CC=CC=C4N(C)C3=O |
Synonyms | GSK 481, GSK-481 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 70 mg/mL (185.48 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.5 mL | 132.49 mL | 264.98 mL |
0.5 mM | 5.3 mL | 26.5 mL | 53 mL |
1 mM | 2.65 mL | 13.25 mL | 26.5 mL |
5 mM | 0.53 mL | 2.65 mL | 5.3 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2